Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 563,341
  • Shares Outstanding, K 78,789
  • Annual Sales, $ 43,470 K
  • Annual Income, $ -17,930 K
  • EBIT $ 104 M
  • EBITDA $ 104 M
  • 60-Month Beta 1.36
  • Price/Sales 2.38
  • Price/Cash Flow N/A
  • Price/Book 1.60

Options Overview Details

View History
  • Implied Volatility 65.72% (-20.85%)
  • Historical Volatility 125.54%
  • IV Percentile 19%
  • IV Rank 18.63%
  • IV High 165.02% on 04/04/25
  • IV Low 42.99% on 08/15/25
  • Expected Move (DTE 2) 0.38 (5.42%)
  • Put/Call Vol Ratio 1.21
  • Today's Volume 1,925
  • Volume Avg (30-Day) 3,081
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 66,643
  • Open Int (30-Day) 58,141
  • Expected Range 6.68 to 7.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.88
  • Number of Estimates 3
  • High Estimate 0.94
  • Low Estimate 0.77
  • Prior Year 0.22
  • Growth Rate Est. (year over year) +300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.01 +0.71%
on 01/12/26
13.02 -45.78%
on 12/30/25
-4.43 (-38.56%)
since 12/12/25
3-Month
7.01 +0.71%
on 01/12/26
13.02 -45.78%
on 12/30/25
-3.52 (-33.27%)
since 10/13/25
52-Week
5.60 +26.07%
on 04/07/25
17.43 -59.50%
on 06/23/25
-4.06 (-36.51%)
since 01/13/25

Most Recent Stories

More News
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...

CRMD : 7.06 (-1.26%)
CorMedix Therapeutics Announces Leadership and Board Updates

BERKELEY HEIGHTS, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...

CRMD : 7.06 (-1.26%)
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

‒ Q4 2025 Unaudited Net Revenue of Approximately $127 million ‒ ‒ FY 2025 Unaudited Pro Forma Net Revenue of Approximately $400 million ‒ ‒ Expects Q4 Adjusted EBITDA of Between $77...

CRMD : 7.06 (-1.26%)
Why CorMedix Could be the Biopharma Name to Watch Early in 2026

CorMedix is a promising biopharma firm in the catheter lock solution space. Continued success for its top products could fuel significant growth into 2026.

CRMD : 7.06 (-1.26%)
MarketBeat’s Top 5 Rated Small-Cap Stocks

Small-cap stocks are regaining momentum as rate cuts and the end of quantitative tightening drive a renewed risk-on environment.

ATAI : 3.67 (-2.39%)
TRVI : 11.29 (unch)
CRMD : 7.06 (-1.26%)
TREE : 62.41 (+6.10%)
MNMD : 14.87 (+7.13%)
IWM : 261.35 (-0.06%)
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

BERKELEY HEIGHTS, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...

CRMD : 7.06 (-1.26%)
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.

TLPH : 1.0300 (unch)
CRMD : 7.06 (-1.26%)
CorMedix: Q3 Earnings Snapshot

CorMedix: Q3 Earnings Snapshot

CRMD : 7.06 (-1.26%)
CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

‒ Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million ‒ ‒ Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million ‒ ‒ FY 2025 Pro Forma...

CRMD : 7.06 (-1.26%)
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

BERKELEY HEIGHTS, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...

CRMD : 7.06 (-1.26%)

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 7.49
2nd Resistance Point 7.40
1st Resistance Point 7.23
Last Price 7.06
1st Support Level 6.97
2nd Support Level 6.88
3rd Support Level 6.71

See More

52-Week High 17.43
Fibonacci 61.8% 12.91
Fibonacci 50% 11.52
Fibonacci 38.2% 10.12
Last Price 7.06
52-Week Low 5.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar